Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Jan;29(1):39–45. doi: 10.1111/j.1365-2125.1990.tb03600.x

Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.

E Blychert 1, K Wingstrand 1, B Edgar 1, K Lidman 1
PMCID: PMC1380059  PMID: 2404502

Abstract

1. The rate and extent of felodipine absorption from an oral solution, conventional and extended-release tablets were investigated in two groups of healthy volunteers (n = 18 + 15). 2. The antihypertensive effect of felodipine conventional tablets twice daily (n = 71) and extended-release tablets once daily (n = 76) were compared in a parallel-group study in hypertensive patients. 3. As from a solution, felodipine was completely absorbed from the two solid dosage forms. The rate of absorption increased in the order extended-release tablets, conventional tablets, solution. 4. The extended-release tablet gave more sustained plasma concentrations than the conventional tablet. 5. The extended-release tablet given once daily gave similar blood pressure control to the conventional tablet given twice daily.

Full text

PDF
39

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahnoff M. Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Anal. 1984;2(3-4):519–526. doi: 10.1016/0731-7085(84)80055-2. [DOI] [PubMed] [Google Scholar]
  2. Ahnoff M., Ervik M., Johansson L. Comparison of high-selectivity gas chromatographic methods, including column switching, for the determination of felodipine in plasma. J Chromatogr. 1987 May 29;394(3):419–427. doi: 10.1016/s0021-9673(01)83809-7. [DOI] [PubMed] [Google Scholar]
  3. Edgar B., Lundborg P., Regårdh C. G. Clinical pharmacokinetics of felodipine. A summary. Drugs. 1987;34 (Suppl 3):16–27. doi: 10.2165/00003495-198700343-00005. [DOI] [PubMed] [Google Scholar]
  4. Edgar B., Regårdh C. G., Johnsson G., Johansson L., Lundborg P., Löfberg I., Rönn O. Felodipine kinetics in healthy men. Clin Pharmacol Ther. 1985 Aug;38(2):205–211. doi: 10.1038/clpt.1985.160. [DOI] [PubMed] [Google Scholar]
  5. Edgar B., Regårdh C. G., Lundborg P., Romare S., Nyberg G., Rönn O. Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses. Biopharm Drug Dispos. 1987 May-Jun;8(3):235–248. doi: 10.1002/bdd.2510080305. [DOI] [PubMed] [Google Scholar]
  6. Felle K., Persson B., Vessman J. Dissolution test for felodipine tablets using chemical oxidation in situ to maintain 'sink conditions'. J Pharm Biomed Anal. 1984;2(3-4):527–536. doi: 10.1016/0731-7085(84)80056-4. [DOI] [PubMed] [Google Scholar]
  7. Hedner T., Samuelsson O., Sjögren E., Elmfeldt D. Treatment of essential hypertension with felodipine in combination with a diuretic. Eur J Clin Pharmacol. 1986;30(2):133–139. doi: 10.1007/BF00614290. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES